Clinical Trial: NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739290) titled 'NAD Supplementation to Reduce the Incidence of Cardiac Surgery Associated Acute Kidney Injury' on July 16.

Brief Summary: The purpose of this single-center, randomized, double-blinded placebo-controlled pilot trial is to demonstrate feasibility and help design a larger trial to assess the effectiveness of nicotinamide (NAM) supplementation in reducing risk of post-operative AKI in patients undergoing cardiac surgery.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Acute Kidney Injury

Intervention: DIETARY_SUPPLEMENT: Nicotinamide (NAM)

A one time 3000 mg nicotinamide dose administered orally on the morning of ...